Page last updated: 2024-10-19

melatonin and Cholangitis, Sclerosing

melatonin has been researched along with Cholangitis, Sclerosing in 2 studies

Cholangitis, Sclerosing: Chronic inflammatory disease of the BILIARY TRACT. It is characterized by fibrosis and hardening of the intrahepatic and extrahepatic biliary ductal systems leading to bile duct strictures, CHOLESTASIS, and eventual BILIARY CIRRHOSIS.

Research Excerpts

ExcerptRelevanceReference

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Ceci, L1
Chen, L1
Baiocchi, L1
Wu, N2
Kennedy, L2
Carpino, G1
Kyritsi, K1
Zhou, T2
Owen, T1
Kundu, D1
Sybenga, A1
Isidan, A1
Ekser, B1
Franchitto, A2
Onori, P2
Gaudio, E2
Mancinelli, R2
Francis, H2
Alpini, G2
Glaser, S2
Meng, F1
Han, Y1
Venter, J1
DeMorrow, S1
Invernizzi, P1
Bernuzzi, F1

Other Studies

2 other studies available for melatonin and Cholangitis, Sclerosing

ArticleYear
Prolonged Administration of Melatonin Ameliorates Liver Phenotypes in Cholestatic Murine Model.
    Cellular and molecular gastroenterology and hepatology, 2022, Volume: 14, Issue:4

    Topics: Animals; Cholangitis, Sclerosing; Cholestasis; Disease Models, Animal; Drinking Water; Glutathione;

2022
Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulation.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2017, Volume: 31, Issue:10

    Topics: Angiogenesis Inducing Agents; Animals; Cell Proliferation; Cholangitis, Sclerosing; Darkness; Diseas

2017